Russell Investments Group
SLDB icon

Russell Investments Group’s Solid Biosciences SLDB Stock Holding History

Russell Investments Group’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64K Buy
8,888
+1,684
+23% +$10.8K ﹤0.01% 3230
2025
Q4 		$40.6K Sell
7,204
-3,007
-29% -$16.3K ﹤0.01% 3374
2025
Q3 		$63K Buy
10,211
+5,991
+142% +$35K ﹤0.01% 3184
2025
Q2 		$20.6K Buy
4,220
+1,809
+75% +$6.39K ﹤0.01% 3184
2025
Q1 		$8.92K Buy
+2,411
New +$10.3K ﹤0.01% 3263
2022
Q3 		– Sell
-1,885
Closed -$17K – 2969
2022
Q2 		$17K Hold
1,885
– – ﹤0.01% 2812
2022
Q1 		$33K Buy
+1,885
New +$33.3K ﹤0.01% 2655
2021
Q3 		– Sell
-5,083
Closed -$279K – 3200
2021
Q2 		$279K Hold
5,083
– – ﹤0.01% 2806
2021
Q1 		$421K Sell
5,083
-657
-11% -$72.7K ﹤0.01% 2593
2020
Q4 		$651K Buy
+5,740
New +$363K ﹤0.01% 2317
2020
Q3 		– Sell
-3,165
Closed -$139K – 3248
2020
Q2 		$139K Buy
+3,165
New +$131K ﹤0.01% 2812

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Russell Investments Group's SLDB Position: Q1 2026 in Review

Russell Investments Group increased its Solid Biosciences (SLDB) stake by 23% in Q1 2026, buying an estimated $10.8K and bringing the position to 8,888 shares worth $64K. The position accounts for ﹤0.01% of the portfolio, ranked #3230.

Russell Investments Group first reported a position in SLDB in Q2 2020 and has held it in 11 quarters since. The position peaked at $651K in Q4 2020. 150 funds tracked by Wall St. Rank hold SLDB as of Q1 2026.

  • Russell Investments Group held 8,888 shares of Solid Biosciences worth $64K as of Q1 2026.
  • Russell Investments Group bought 1,684 Solid Biosciences shares in Q1 2026, an estimated $10.8K.
  • Solid Biosciences made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3230 holding.
  • Russell Investments Group first reported a position in Solid Biosciences in Q2 2020 and has held it in 11 quarters since.
  • Russell Investments Group's Solid Biosciences position peaked at $651K in Q4 2020.
  • 150 funds tracked by Wall St. Rank held Solid Biosciences as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.